Pancreatic Cancer

The approval was based on data from the phase 3 NAPOLI-1 trial, which demonstrated a 1.9-month improvement in overall survival (OS) with the addition of Onivyde to 5-FU and leucovorin.

The Pancreatic Cancer Action Network offers webinars, where listeners can learn about various topics from the comfort of their homes.

MARGARET WHALEN is my kind of nurse!

Julie Fleshman, JD, MBA, president, CEO, Pancreatic Cancer Action Network, discusses the role of nutrition in the life of a patient with pancreatic cancer.

Michael Ferraro, executive chef, Delicatessen, discusses his mother's journey with pancreatic cancer and his role in the Cooking. Comfort. Care. Nourishment for the Pancreatic Cancer Fight program.

The treatment landscape for advanced pancreatic cancer has expanded in recent years, but it continues to be a very complex and devastating disease.

Min Li, of the University of Texas Health Sciences Health Science Center in Houston, offers dietary and lifestyle suggestions for newly diagnosed pancreatic cancer patients.

Changing the administration schedule for Gemzar (gemcitabine) plus Abraxane (nab-paclitaxel) from weekly to every other week significantly reduced side effects without impacting efficacy as a frontline treatment for patients with metastatic pancreatic cancer, according to a retrospective study presented at the 2015 GI Cancers Symposium.

An analysis of the phase 3 NAPOLI-1 trial supports the benefits of adding MM-398 chemotherapy for the treatment of patients with metastatic pancreatic cancer who were previously treated with Gemzar.

Small, yet significant, advances are reshaping pancreatic cancer treatment.

Early research shows promise in screening and detecting pancreatic cancer at its earliest stages.

When advocates unite, they can move a nation to act.

Cancer research updates from the American Society of Clinical Oncology's annual symposium on gastrointestinal cancers.

A new law hopes to boost survival in rare cancers.

Patients and families face difficult decisions when the prognosis is poor, but communication and an action plan may help.

Quality Control: Even with metastatic cancer, many patients live long and well.

The latest in cancer prevention, diagnosis, and treatment.

Information about The Pancreatic Cancer Symposia

KRAS gene mutations are detected in various cancers, including colorectal.